Clinical Trials Browser

INDUSTRY × Graft vs Host Disease × Alemtuzumab × Clear all

NCT00781781 2015-02-04

Alemtuzumab Use (MabCampath®) in Hematopoietic Transplant of Unrelated Donor With Reduced Intensity Conditioning

Phase 2 Terminated

Graft vs Host Disease